跳至主要内容
临床试验/IRCT20160530028173N5
IRCT20160530028173N5招募中3 期

Comparison of the effects and side effects of the three drugs risperidone, quetiapine and olanzapine in the treatment of psychosis symptoms due to Shisheh

Tabriz University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Having criteria for glass-induced psychosis disorder based on DSM-5 (through clinical interview by psychiatrist).
  • Treated with one of the antipsychotics risperidone, quetiapine and olanzapine
  • No other psychiatric disorders
  • Willingness of an individual or family (conscious consent) to participate in the study
  • Minimum age 18
  • If you have a history of drug treatment for the above disorder, at least three weeks have passed since you stopped taking the drug

排除标准

  • History of mental disorders
  • History of epilepsy
  • History of brain trauma
  • Taking drugs other than target group treatment drugs
  • Unwillingness of the patient or the family to continue cooperating in the study for any reason
  • Incomplete questionnaires
  • If a sample has other psychiatric disorders, including personality disorders, it will be excluded from the plan and will continue its routine treatment.
  • Incidence of drug complications based on the AIMS scale

研究者

相似试验

Efficacy and side effects of risperidone, quetiapine... | 临床试验